SI21221A - Hitro razpadljive tablete - Google Patents

Hitro razpadljive tablete Download PDF

Info

Publication number
SI21221A
SI21221A SI200200160A SI200200160A SI21221A SI 21221 A SI21221 A SI 21221A SI 200200160 A SI200200160 A SI 200200160A SI 200200160 A SI200200160 A SI 200200160A SI 21221 A SI21221 A SI 21221A
Authority
SI
Slovenia
Prior art keywords
tablets
rapidly disintegrating
disintegrating tablet
tablet according
amoxicillin
Prior art date
Application number
SI200200160A
Other languages
English (en)
Slovenian (sl)
Inventor
Vesna �Kulj
Judita �irca
Osel Maja Jenko
Original Assignee
LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. filed Critical LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d.
Priority to SI200200160A priority Critical patent/SI21221A/sl
Priority to PCT/EP2003/006528 priority patent/WO2004000281A1/en
Priority to EA200500031A priority patent/EA012324B1/ru
Priority to PL373034A priority patent/PL206248B1/pl
Priority to SI200331391T priority patent/SI1534245T1/sl
Priority to EP03760665A priority patent/EP1534245B1/en
Priority to AU2003249856A priority patent/AU2003249856A1/en
Priority to AT03760665T priority patent/ATE401060T1/de
Priority to US10/518,731 priority patent/US20060115528A1/en
Priority to DE60322228T priority patent/DE60322228D1/de
Publication of SI21221A publication Critical patent/SI21221A/sl
Priority to US13/269,050 priority patent/US20120028949A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SI200200160A 2002-06-21 2002-06-21 Hitro razpadljive tablete SI21221A (sl)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SI200200160A SI21221A (sl) 2002-06-21 2002-06-21 Hitro razpadljive tablete
EP03760665A EP1534245B1 (en) 2002-06-21 2003-06-20 Rapidly disintegrating tablet
EA200500031A EA012324B1 (ru) 2002-06-21 2003-06-20 Быстрораспадающаяся таблетка
PL373034A PL206248B1 (pl) 2002-06-21 2003-06-20 Rozpadająca się w ustach lub dyspergowalna tabletka oraz sposób jej wytwarzania
SI200331391T SI1534245T1 (sl) 2002-06-21 2003-06-20 Hitro razpadljiva tableta
PCT/EP2003/006528 WO2004000281A1 (en) 2002-06-21 2003-06-20 Rapidly disintegrating tablet
AU2003249856A AU2003249856A1 (en) 2002-06-21 2003-06-20 Rapidly disintegrating tablet
AT03760665T ATE401060T1 (de) 2002-06-21 2003-06-20 Schnell zerfallende tablette
US10/518,731 US20060115528A1 (en) 2002-06-21 2003-06-20 Rapidly disintegrating tablet
DE60322228T DE60322228D1 (de) 2002-06-21 2003-06-20 Schnell zerfallende tablette
US13/269,050 US20120028949A1 (en) 2002-06-21 2011-10-07 Rapidly Disintegrating Tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200200160A SI21221A (sl) 2002-06-21 2002-06-21 Hitro razpadljive tablete

Publications (1)

Publication Number Publication Date
SI21221A true SI21221A (sl) 2003-12-31

Family

ID=29778203

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200200160A SI21221A (sl) 2002-06-21 2002-06-21 Hitro razpadljive tablete
SI200331391T SI1534245T1 (sl) 2002-06-21 2003-06-20 Hitro razpadljiva tableta

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200331391T SI1534245T1 (sl) 2002-06-21 2003-06-20 Hitro razpadljiva tableta

Country Status (9)

Country Link
US (2) US20060115528A1 (ru)
EP (1) EP1534245B1 (ru)
AT (1) ATE401060T1 (ru)
AU (1) AU2003249856A1 (ru)
DE (1) DE60322228D1 (ru)
EA (1) EA012324B1 (ru)
PL (1) PL206248B1 (ru)
SI (2) SI21221A (ru)
WO (1) WO2004000281A1 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
RU2391115C2 (ru) * 2004-12-13 2010-06-10 МакНЕЙЛ-ППС, ИНК. Композиции и способы стабилизации активных фармацевтических ингредиентов
WO2007058397A1 (en) * 2005-11-17 2007-05-24 Gl Pharmtech Corp. A dispersible tablet comprising the mixture of amoxicillin and clavulanic acid or its salts and processes for preparing the same
AR061485A1 (es) * 2006-06-15 2008-08-27 Serenex Inc Composiciones estabilizadas de tetraciclina
BR112014016850A8 (pt) * 2012-01-10 2017-07-04 Hoberman Alejandro composição líquida para o tratamento de otite media pediátrica, suspensão oral pediátrica, método de tratamento de otite média pediátrica em pacientes com menos de 24 meses de idade e método de tratamento de haemophilus influenzae, e moraxella catarrhalis produtoras de beta-lactamase em pacientes pediátricos com menos de 24 meses de idade
WO2013173803A2 (en) * 2012-05-17 2013-11-21 Michael Spector Formulations of amoxicillin and clavulanate potassium and methods for using same
WO2013173808A2 (en) * 2012-05-17 2013-11-21 Michael Spector Methods for use of lower dose compositions of amoxicillin and clavulanate potassium and devices for use
US9254261B2 (en) 2014-03-03 2016-02-09 Sandoz Ag Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid
US20160008310A1 (en) 2014-07-11 2016-01-14 Azanta A/S Misoprostol dispersible tablet
TN2017000003A1 (en) 2014-07-11 2018-07-04 Azanta Danmark As Misoprostol dispersible tablet.
CN104173601B (zh) * 2014-08-20 2017-11-07 黑龙江天翼药业有限公司 板蓝大青片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9200139A (en) * 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
DK0833642T3 (da) * 1995-06-22 2002-06-10 Akzo Nobel Nv Komprimerede tør-granulerede desogestreltabletter
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
US5985823A (en) * 1997-06-09 1999-11-16 Ambi Inc. Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
US6200604B1 (en) * 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
US6368625B1 (en) * 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
US6117451A (en) * 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets
US6660303B2 (en) * 1999-12-06 2003-12-09 Edward Mendell & Co. Pharmaceutical superdisintegrant

Also Published As

Publication number Publication date
PL206248B1 (pl) 2010-07-30
EP1534245B1 (en) 2008-07-16
SI1534245T1 (sl) 2009-02-28
PL373034A1 (en) 2005-08-08
AU2003249856A1 (en) 2004-01-06
EA012324B1 (ru) 2009-08-28
WO2004000281A1 (en) 2003-12-31
US20120028949A1 (en) 2012-02-02
DE60322228D1 (de) 2008-08-28
EP1534245A1 (en) 2005-06-01
ATE401060T1 (de) 2008-08-15
EA200500031A1 (ru) 2005-08-25
US20060115528A1 (en) 2006-06-01

Similar Documents

Publication Publication Date Title
RU2201216C2 (ru) Быстро расщепляющаяся фармацевтическая лекарственная форма
US20040071772A1 (en) Preparations quickly disintegrating in oral cavity
US20120028949A1 (en) Rapidly Disintegrating Tablet
JP5859664B2 (ja) 薬物の味がマスクされた経口用薬学組成物及びその製造方法
AU2001227915A1 (en) Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
ES2201465T3 (es) Formulado de comprimidos de monohidrato de cefadroxil.
JP5630902B2 (ja) ゾルピデム酒石酸塩含有口腔内崩壊錠の製造方法
AU2002364468C1 (en) Solid orally-dispersible pharmaceutical formulation
JP2007507548A (ja) 速崩壊型製剤
KR20050062514A (ko) 경구 투여용 분산성 정제
JP2017141299A (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
KR20070069175A (ko) 구강 내 용해용 고형 제제
AU2007338751A1 (en) Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
EP3643325B1 (en) A composition comprising furazidin and a method of its manufacturing
UA79567C2 (en) Orodispersible pharmaceutical composition of antithrombolic compound
JP2005029557A (ja) 口腔内速崩壊性錠剤およびその製造方法
CA2298487C (en) A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets
Shinde et al. Formulation and Evaluation of Fast Dissolving Tablet of Drug Used In the Treatment of Motion Sickness
Kumar et al. Formulation and evaluation of Sultamicillin dispersible tablets
CN113679687A (zh) 一种复合释药组合物、口崩片组合物和口崩制剂及其应用
Laxmi Formulation and Evaluation of Ondansetron Hydrochloride Mouth Dissolving Tablets
Sasikumar FORMULATION DEVELOPMENT AND EVALUATION OF TASTE MASKED CHEWABLE TABLET 0F SILDENAFIL CITRATE Dissertation submitted to
TR2021001998A2 (tr) Pelargoni̇um türleri̇ni̇ i̇çeren bi̇r efervesan bi̇leşi̇m
JP2019203031A (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
Vardhelli Formulation and Evaluation of Mouth Dissolving Tablets Containing a Macrolide Antibiotic

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20110127